6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scoote, M; Ward, BJ | 1 |
| Alam, J; Das, DK; Ho, YS; Maulik, N; Yoshida, T | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Myocardial Ischemia
| Article | Year |
|---|---|
Antioxidants attenuate postischemic endothelial cell swelling and luminal membrane blebbing in cardiac capillaries.
Topics: Animals; Antioxidants; Capillaries; Catalase; Cell Size; Chromans; Drug Evaluation, Preclinical; Endothelium, Vascular; Male; Membranes; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin E | 1997 |
H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene.
Topics: Acetylcysteine; Animals; Antioxidants; Chromans; Creatine Kinase; Disease Models, Animal; Gene Targeting; Heart; Heart Rate; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Heterozygote; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Malondialdehyde; Membrane Proteins; Mice; Mice, Transgenic; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Reperfusion Injury; Thiourea | 2001 |